Capricor Therapeutics, Inc.
NASDAQ:CAPR
14.01 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 25.178 | 2.549 | 0.245 | 0.31 | 1.005 | 1.671 | 1.367 | 3.19 | 3.776 | 4.787 | 0.503 | 0.196 | 1.355 | 0 | 0 | 0 | 0.101 | 0 | 0 | 0 | 0.002 | 0.011 | 0 | 0 | 0 |
| Cost of Revenue
| 1.069 | 0.695 | 0.246 | 8.457 | 5.142 | 12.067 | 10.766 | 16.042 | 13.757 | 7.787 | 5.197 | 2.634 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 24.109 | 1.854 | -0.001 | -8.147 | -4.137 | -10.395 | -9.399 | -12.852 | -9.981 | -3.001 | -4.694 | -2.439 | 1.355 | 0 | 0 | 0 | 0.101 | 0 | 0 | 0 | 0.002 | 0.011 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.958 | 0.727 | -0.003 | -26.259 | -4.116 | -6.22 | -6.875 | -4.029 | -2.643 | -0.627 | -9.328 | -12.474 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 36.448 | 21.817 | 13.571 | 8.457 | 5.142 | 12.067 | 10.766 | 16.042 | 13.757 | 7.787 | 5.197 | 1.024 | 4.137 | 4.081 | 4.467 | 9.478 | 5.124 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 12.366 | 10.432 | 7.612 | 5.543 | 3.597 | 4.932 | 4.763 | 4.933 | 4.372 | 3.017 | 2.209 | 1.612 | 2.117 | 2.213 | 3.417 | 3.922 | 4.478 | 0.06 | 0.019 | 0.019 | 0.018 | 0.029 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0 |
| SG&A
| 12.366 | 10.432 | 7.612 | 5.543 | 3.597 | 4.932 | 4.763 | 4.933 | 4.372 | 3.017 | 2.209 | 1.612 | 2.117 | 2.213 | 3.417 | 3.922 | 4.478 | 0.06 | 0.019 | 0.019 | 0.018 | 0.029 | 0.022 | 0.01 | 0 |
| Other Expenses
| 0 | 0.191 | 0.548 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.546 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.026 | 0 |
| Operating Expenses
| 48.187 | 32.249 | 21.183 | 14 | 8.739 | 16.998 | 14.23 | 20.167 | 16.388 | 10.805 | 7.406 | 2.636 | 6.254 | 6.294 | 7.884 | 13.4 | 9.602 | 0.06 | 0.019 | 0.019 | 0.018 | 0.029 | 0.022 | 0.037 | 0 |
| Operating Income
| -24.078 | -29.697 | -20.938 | -13.69 | -7.734 | -15.327 | -12.862 | -16.977 | -12.612 | -6.018 | -6.903 | -2.44 | -4.899 | -6.294 | -7.884 | -13.4 | -9.5 | -0.06 | -0.019 | -0.019 | -0.016 | -0.018 | -0.022 | -0.037 | -0 |
| Operating Income Ratio
| -0.956 | -11.651 | -85.499 | -44.126 | -7.695 | -9.17 | -9.408 | -5.322 | -3.34 | -1.257 | -13.717 | -12.482 | -3.617 | 0 | 0 | 0 | -93.693 | 0 | 0 | 0 | -7.398 | -1.548 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.79 | 0.678 | 0.916 | 0.033 | 0.092 | 0.136 | 15.294 | -1.83 | -0.246 | -0.199 | -1.989 | 0.207 | 0.014 | 0.262 | 0.011 | 0.268 | -0.802 | -0.001 | 0 | 0.001 | 0.016 | 0.002 | 0 | 0 | 0 |
| Income Before Tax
| -22.288 | -29.02 | -20.023 | -13.657 | -7.642 | -15.191 | 2.431 | -18.807 | -12.857 | -6.217 | -8.892 | -1.893 | -4,884.786 | -6,031.491 | -7,872.297 | -13,131.596 | -10.303 | -0.061 | 0 | -0.018 | 0 | -0.016 | 0 | 0 | 0 |
| Income Before Tax Ratio
| -0.885 | -11.385 | -81.759 | -44.019 | -7.604 | -9.089 | 1.778 | -5.895 | -3.405 | -1.299 | -17.67 | -9.683 | -3,606.339 | 0 | 0 | 0 | -101.605 | 0 | 0 | 0 | 0 | -1.357 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | -0.001 | -0.613 | -0.177 | -0.264 | 0.136 | 0.255 | 0.219 | 0.138 | 0.201 | 0.058 | 0 | -0.014 | -0.262 | -0.011 | -0.268 | 1.09 | 0 | 0.019 | 0 | 0.016 | 0 | 0 | 0 | 0 |
| Net Income
| -22.288 | -29.019 | -19.409 | -13.48 | -7.378 | -15.191 | 2.431 | -18.807 | -12.857 | -6.217 | -8.892 | -1.893 | -4.885 | -6.031 | -7.872 | -13.132 | -10.303 | -0.061 | -0.019 | -0.018 | -0.016 | -0.016 | -0.022 | -0.037 | -0 |
| Net Income Ratio
| -0.885 | -11.385 | -79.254 | -43.449 | -7.341 | -9.089 | 1.778 | -5.895 | -3.405 | -1.299 | -17.67 | -9.683 | -3.606 | 0 | 0 | 0 | -101.605 | 0 | 0 | 0 | -7.398 | -1.357 | 0 | 0 | 0 |
| EPS
| -0.83 | -1.18 | -0.84 | -0.87 | -1.99 | -5.17 | 1 | -10.14 | -8.09 | -5.31 | -8.47 | -1.9 | -65.43 | -93.75 | -154.56 | -272.15 | -304.06 | -2.22 | -12.49 | -11.97 | -10.7 | -10.32 | -14.77 | -26.56 | -0.2 |
| EPS Diluted
| -0.83 | -1.18 | -0.84 | -0.87 | -1.99 | -5.17 | 0.9 | -10.14 | -8.09 | -5.31 | -8.47 | -1.9 | -65.43 | -93.75 | -154.56 | -272.15 | -304.06 | -2.22 | -12.49 | -11.97 | -10.7 | -10.32 | -14.77 | -26.56 | -0.2 |
| EBITDA
| -23.009 | -29.164 | -20.693 | -13.546 | -7.562 | -15.169 | -12.718 | -18.327 | -12.498 | -5.974 | -6.876 | -1.887 | -4.877 | -6.019 | -7.713 | -13.018 | -9.5 | -2.498 | -0.019 | -0.02 | -0.016 | -0.02 | -0.022 | -0.036 | 0 |
| EBITDA Ratio
| -0.914 | -11.842 | -87 | -44.232 | -7.787 | -9.17 | -9.408 | -5.322 | -3.34 | -1.248 | -13.664 | -12.443 | -3.618 | 0 | 0 | 0 | -93.427 | 0 | 0 | 0 | -7.398 | -1.739 | 0 | 0 | 0 |